I agree with you Tommy. I have been using the ACV to forecast the next qtr cash flow. Based on the 31 Jan 19 ACV of $0.93m, my estimate of the Mar 19 Qtr cash flow was $0.23m ($0.93m/4) . The actual result was $0.43m was much higher than expected and we now know that this was due to prepayments. My estimate for the Jun 19 Qtr cf was $0.33m based on the 30 Apr 19 ACV of $1.32m. The actual result of $0.21m was lower due to the prepayments received in Mar 19. Based on the new 31 Jul 19 ACV of $1.85m my estimate of cf for the Sep 19 qtr is $0.46m. 3DP is starting to close in on revenue for cf breakeven of around $0.7m per qtr which could be within the next 6 months based on current quarterly growth in ACV and with the current cost disciplines of 3DP management being maintained. AIMO
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
I agree with you Tommy. I have been using the ACV to forecast...
Featured News
Add 3DP (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.3¢ |
Change
0.003(7.50%) |
Mkt cap ! $34.61M |
Open | High | Low | Value | Volume |
4.1¢ | 4.3¢ | 4.1¢ | $15.79K | 369.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 43964 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 35000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 43964 | 0.042 |
4 | 147583 | 0.041 |
5 | 235024 | 0.040 |
4 | 1251008 | 0.039 |
7 | 590288 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 35000 | 2 |
0.045 | 14682 | 2 |
0.046 | 19786 | 2 |
0.047 | 5505 | 1 |
0.048 | 12837 | 1 |
Last trade - 15.21pm 18/11/2024 (20 minute delay) ? |
Featured News
3DP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online